drugset
drugset / Trial / NCT02759861

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

NCT02759861 ↗

Phase 4 Completed 16 enrolled University of Nebraska
NaSingle-groupOpen-labelTreatment

Summary

To determine the efficacy and safety of Harvoni in treatment-naïve alcoholic subjects with Genotype 1 HCV infection

Timeline

Start
2016-08-01
Primary completion
2020-08-01
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sofosbuvir Small molecule — —

Indications

chronic hepatitis C virus infection